Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

White Meets Blue - Enzymicals AG and the Institute of Marine Biotechnologye.V. start to cooperate

14.06.2011
The Enzymicals AG, an emerging company in the field of industrial (white) biotechnology, and the Institute of Marine Biotechnology e.V. (IMaB), an association in the area of marine (blue) biotechnology, have signed a comprehensive agreement to cooperate in the future.The two institutions both located in Greifswald, Germany, combine thereby their competencies in the commercialization of alternative expression systems and functional genome analysisfor the production of fine chemicals.

The signed contract includes the joint use of innovative technologies for the identification and production of novel enzymes from aquatic sources,amongst others. “Dormant potentials of marine habitats for biotransformations can be deciphered and brought into market by the focused application of proteomics-based biotechnology”, says Prof. Dr. Thomas Schweder of the IMaB. ”Together with Enzymicals AG, we can offer our expertise in the field of de novo genome sequencing and gene annotation to a wide audience as a service.”

Thewhole value chain can be covered jointly by merchandising of new biocatalysts from aquatic systems and the application-oriented process development by Enzymicals AG.

The two institutionscomplement each other in their strategic alignment perfectly by the construction of expression systems and production strains for applications in fine chemistry.

“Thus, our customers will gain access to exquisite biocatalysts for applications in the chemical and pharmaceutical industry”, adds Dr. Ulf Menyes, CEO of Enzymicals AG, who foresees a strengthening of core competencies by the partnership.

Both new and existing customers will gain a long-term competitive advantage in tailored product and process development based on innovative biocatalysts from the cooperation of both institutions.

About Enzymicals AG:
The Enzymicals AG, Greifswald, was founded as a start-up company in August 2009, initialized by the workgroup of Prof. UweBornscheuer, Institute of Biochemistry at the University of Greifswald. The company specializes in enzymatic reactions for the production of fine and specialty chemicals and the manufacture and sale of biocatalysts.

The interdisciplinary team of biochemists, biologists, synthetic and process chemists is led by Dr. Ulf Menyes (chemist) as chief executive officer (CEO) and Dr. Rainer Wardenga (biologist) as head of research and production (CSO). The Enzymicals AG has establishedcollaborations with leading companies in the chemical industry and established the technical requirements for the production of enzymes and for the biotechnological synthesis of specialty and fine chemicals on kg-scalewithin a short period of time. Enzymicals is member of BioCon Valley MV e.V.

About the Institute of Marine Biotechnologye.V.:
The Institute of Marine Biotechnology e.V. (IMaB) was founded in 1996. The main concern of the institute is to promote and develop research in the field of marine biotechnology. This is done in close cooperation with the Ernst-Moritz-ArndtUniversity of Greifswald. Research interests of the IMaB include the functional genome and proteome analysis of marine microorganisms, the discovery, enrichment and characterization of bioactive compounds from marine organisms and the development of new bacterial expression systems.

A particular focus is on the field of functional genomics of marine microorganisms. The increasing number of sequenced genomes of marine bacteria and the extensive data on marine metagenomes allow a comprehensive insight into the previously unknown metabolic activities of marine organisms. The functional genome analysis is substantially supported by the analysis of the physiological proteome. One of the most modern and best equipped proteome centers in Germany was established at the University of Greifswald in recent years. These technologies are used by the IMaB to determine relevant, new gene functions and to make them accessible for biotechnological applications. The Institute is member of BioCon Valley MV e.V.

Contact:
Enzymicals AG
Dr. Ulf Menyes, CEO
Walther-Rathenau-Str. 49a
17489 Greifswald, Germany
Tel.: +49-3834-515 470
Fax.: +49-3834-515 473
E-Mail: ulf.menyes@enzymicals.com
Institutfür Marine Biotechnologiee.V.
Prof. Dr. Thomas Schweder
Walther-Rathenau-Str. 49A
D-17489 Greifswald
Tel.: +49(0)3834 864212
Fax +49(0)3834 864238
E-Mail: schweder@uni-greifswald.de

Dr. Heinrich Cuypers | idw
Further information:
http://www.enzymicals.com
http://www.marine-biotechnologie.de
http://www.bcv.org

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>